Uterine Artery Blood Flow in Pregnant Women With Polycystic Ovary Syndrome(PCOS)Treated With Metformin - a Substudy to The PregMet Study
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention
Pulsatility index of the uterine artery
3 hrs before and after drug intake, 2 weeks after inclusion, and during medication
up to delivery
No
Eszter Vanky, MD, Phd
Principal Investigator
Norwegian University of Science and Technology
Norway: Norwegian Medicines Agency
2004-000792-33
NCT00466622
April 2007
February 2010
Name | Location |
---|